Molecular Imaging Clinic
Providers can now order PET/CT scans at BAMF Health’s Molecular Imaging Clinic, utilizing the uExplorer Total Body PET/CT – the only scanner of its kind in clincal use in the United States.
Capable of total body scans in under 60 seconds. Improves patient experience and potentially eliminates claustrophobia. Capable of any PET/CT Study: FDG, PSMA, Ga68-Dotatate.
40x more sensitive than traditional PET scanning technology. Better images could change staging or avoid unnecessary procedures.
Molecular Therapy Clinic
Providers can now refer patients for Theranostics at the BAMF Health Molecular Therapy Clinic
Pluvicto® (Lu-177-PSMA-617) indicated for metastatic castration resistant prostate cancer post hormone therapy and taxane-based chemotherapy
Lutathera® (Lu-177-DOTATATE) for treatment of gastroenteropancreatic neuroendocrine tumor (GEP-NET)
Post-therapy Dosimetry utilizing world’s most advanced digital SPECT/CT, GE Starguide
Advanced Clinical Trials
Providers can now refer patients to BAMF Health’s Advanced Clinical Trials.
BAMF Health is Now Enrolling Patients in the ECLIPSE Trial for Prostate Cancer Patients.
Additional trials will be initiated in 2023. Please check back soon for additional details.